Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with left ventricular remodeling and improved diastolic function

American Journal of Cardiology

Volumn 78, Issue 1, 1996, Pages 56-60

  Schulman, Douglas S ^a,b   Flores, Angel R ^a   Tugoen, John ^a   Dianzumba, Sinda ^a   Reichek, Nathaniel ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; FELODIPINE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; EXERCISE TEST; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MALE; PRIORITY JOURNAL;

EID: 0030201028     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00227-5     Document Type: Article

References (30)

1. 1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1651-1656.
2. 2. Smith VE, Schulman P, Karimeddini MK, White WB, Meeran MK, Katz A. Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy. J Am Coll Cardiol 1985;5:869-874.
3. 3. Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P, Tubau J. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol 1084;53:120-126.
4. 4. Fouad FM, Slominski M, Tarazi RC. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coll Cardiol 1984;3:1500-1506.
5. 5. Liebson PR. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens 1990;3:512-517.
6. 6. Schulman SP, Weiss JL, Becker LC, Gottlieb SO, Woodruff KM, Weisfeldt ML, Gerstenblith G. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med 1990;322:1350-1356.
7. 7. Grandi AM, Venco A, Bertolini A, Pantaleo P, Corbellini D, Perani G, Folino P, Gobbi G, Finardi G. Left ventricular function after reversal of myocardial hypertrophy in systemic hypertension, and response to acute increase of afterioad by cold pressor test. Am J Cardiol 1992;69:1439-1441.
8. 8. Smith VE, White WQB, Meeran MK, Karimeddini MK. Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. J Am Coll Cardiol 1986;8:1449-1454.
9. 9. Grandi AM, Venco A, Barizza F, Casadei B, Marchesi E, Finardi G. Effects of enalapril on left ventricular mass and performance in essential hypertension. Am J Cardiol 1989;63:1093-1097.
10. 10. Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JH. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986;7:639-650.
11. 11. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19:1550-1558.
12. 12. Dianzumba SB, DiPette DJ, Cornman C, Weber E, Joyner CR. Left ventricular filling characteristics in mild untreated hypertension. Hypertension 1986;8(suppl I):I-156-I-160.
13. 13. Schulman DS, Tugoen JF, Flores AR, Dianzumba S, Reichek N. Left ventricular ejection fraction during supine and upright exercise in systemic hypertension and its relation to peak filling rate. Am J Cardiol 1995;76:61-65.
14. 14. Schulman DS, Herman BA, Ziady G, Edwards T, Kormos R, Reddy PS, Follansbee WP, Uretsky BF. Effects of acute alterations in left ventricular loading conditions on peak filling rate in the denervated (transplanted) ventricle. Am J Cardiol 1991;67:1103-1109.
15. 15. Nichols K, Adatepe MH, lssacs GH, Powell OM, Pittman DE, Gay TC, Begg FR. A new scintigraphic method for determining left ventricular volumes. Circulation 1984;70:672-678.
16. 16. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification on M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1081.
17. 17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
18. 18. Devereux RB, Lutas EM, Caasale PN, Kligfield P, Eisenberg RR, Hammond IW, Miller DH, Reis G, Alderman MH, Laragh JH. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984;4:1222-1230.
19. 19. Magorien DJ, Shaffer P, Bush C, Magorien RD, Kolibash AJ, Unverferth DV, Bashore TM. Hemodynamic correlates for timing intervals, ejection rate and filling rate derived from the radionuclide angiographic volume curve. Am J Cardiol 1984;53:567-571.
20. 20. Choong CY, Abascal VM, Thomas JD, Guerrero JL, McGlew S, Weyman AE. Combined influence of ventricular loading and relaxation on the transmitral flow velocity profile in dogs measured by Doppler echocardiography. Circulation 1988;78:672-683.
21. 21. Bahler RC, Martin P. Effects of loading conditions and inotropic state on rapid filling phase of left ventricle. Am J Physiol 1985;248:H523-H533.
22. 22. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989;64;1041-1050.
23. 23. Muir AL, Wathen CG, Elevelin L. Effects of felodipine and nifedipine on left ventricular performance in hypertensive patients. Curr Ther Res 1992;52:677-680.
24. 24. Cheng C, Igarashi Y, Pettersson K, Little WC. Effect of felodipine on left ventricular performance in conscious dogs: assessment by left ventricular pressure-volume analysis. J Pharmacol Exp Ther 1991;257:163-169.
25. 25. Timmis AD, Campbell S, Monaghan MJ, Walker L, Jewitt DE. Acute haemodynamic and metabolic effects of felodipine in congestive heart failure. Br Heart J 1984;51:445-451.
26. 26. Brush JE Jr, Cannon RO III, Schenke WH, Bonow RO, Leon MB, Maron BJ, Epstein SE. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988;319:1302-1307.
27. 27. Inouye IK, Massie BM, Loge D, Simpson P, Tubau JF. Failure of antihypertensive therapy with diuretic, beta-blocking and calcium channel-blocking drugs to consistently reverse left ventricular diastolic filling abnormalities. Am J Cardiol 1984;53:1583-1587.
28. 28. Hwang Y, Yen H, Wong ECK. Efficacy of once-daily felodipine monotherapy in systemic hypertension. Am J Cardiol 1992;69:271-274.
29. 29. Smith SA, Mace PJE, Littler WA. Felodipine, blood pressure, and cardiovascular reflexes in hypertensive humans. Hypertension 1986;8:1172-1178.
30. 30. Cerasola G, Cottone S, Nardi E, Fulantelli MA, Carone MB, D'Ignoto G. Reversal of cardiac hypertrophy and left ventricular function with the calcium antagonist felodipine in hypertensive patients. J Hum Hypertens 1990;4:703-708.